- Report
- April 2025
- 200 Pages
Global
From €4150EUR$4,490USD£3,498GBP
- Report
- November 2022
- 230 Pages
Global
From €3466EUR$3,750USD£2,922GBP
- Report
- April 2021
China
From €2403EUR$2,600USD£2,026GBP
- Report
- January 2024
- 143 Pages
Global
From €3928EUR$4,250USD£3,311GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €462EUR$500USD£390GBP
Protopic is a topical immunomodulator used to treat immune disorders such as atopic dermatitis, also known as eczema. It is a calcineurin inhibitor, which works by suppressing the body's immune response to reduce inflammation and itching. Protopic is available in both ointment and cream forms, and is typically applied twice daily. It is generally used as a short-term treatment, and is not recommended for long-term use due to potential side effects.
Protopic is a relatively new drug, and is one of the few topical treatments available for immune disorders. It is often used as an alternative to systemic immunosuppressants, which can have more serious side effects. Protopic is generally well-tolerated, and is considered a safe and effective treatment for atopic dermatitis.
Some companies in the Protopic market include Novartis, Pfizer, and GlaxoSmithKline. These companies produce and market Protopic, as well as other topical treatments for immune disorders. Show Less Read more